Shared Care for Patients With Type 2 Diabetes Across the Primary and Secondary Health Care Sector
1 other identifier
interventional
140
1 country
1
Brief Summary
The aim of the study is to test the effect of a new shared care model for type 2 diabetes care and compare it with a standardized care management program in a specialized hospital-based out-patient clinic. The hypothesis is that participants with type 2 diabetes followed in a shared care program will have a comparable outcome in HbA1c to participants receiving standard care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable diabetes-mellitus-type-2
Started Aug 2015
Longer than P75 for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 21, 2015
CompletedFirst Posted
Study publicly available on registry
October 26, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedJanuary 3, 2019
January 1, 2019
3.3 years
October 21, 2015
January 2, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Change from baseline Hemoglobin A, Glycosylated (HbA1c) at 12, 24 and 36 months
Baseline and follow-up at 12, 24 and 36 months
Secondary Outcomes (1)
The proportion of patients who meet national standard indicators reflecting quality of care
Follow-up at 12, 24 and 36 months after baseline
Other Outcomes (3)
Change from baseline Quality of life at 12, 24 and 36 months
Baseline and follow-up at 12, 24 and 36 months
Change from baseline blood pressure at 12, 24 and 36 months
Baseline and follow-up at 12, 24 and 36 months
Change from baseline diabetes symptoms at 12, 24 and 36 months
Baseline and follow-up at 12, 24 and 36 months
Study Arms (2)
Shared care model
EXPERIMENTALFour visits a year: one annual comprehensive check-up at the outpatient diabetes clinic and three quarterly visits at the general practitioner.
Mono sectorial care
NO INTERVENTIONTreament as usual including four visits a year with the diabetes team at the outpatient clinic: an annual comprehensive check-up, identical to the one received by the intervention group, and three quarterly visits.
Interventions
Eligibility Criteria
You may qualify if:
- Must be over the age of 18 years
- The diagnosis of type 2 diabetes
- Risk stratification level 2
- Capable of speaking and writing in Danish
- Give oral and written consent before entering the study
You may not qualify if:
- Diagnosed with other types of diabetes than type 2 diabetes
- Risk stratification level 1 or 3
- Being pregnant or breastfeeding
- Having severe co-morbidity with life expectancy less than five years
- Being under such conditions, that the patient will not be able to show up or go through with the appointments (e.g. moderate to severe dementia and severe psychiatric conditions)
- Participating in long-lasting interventions (\>2 weeks) that potentially affects the primary outcome in our study or patients participating in studies which include blood sampling amounting to \>5 % of the blood volume two months prior to the randomisation and/or the follow-up visits
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Center for Diabetes Research, Gentofte Hospital, University of Copenhagen
Hellerup, DK-2900, Denmark
Related Publications (1)
Munch L, Bennich B, Arreskov AB, Overgaard D, Konradsen H, Knop FK, Vilsboll T, Roder ME. Shared care management of patients with type 2 diabetes across the primary and secondary healthcare sectors: study protocol for a randomised controlled trial. Trials. 2016 Jun 4;17(1):277. doi: 10.1186/s13063-016-1409-y.
PMID: 27259669DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lene Munch, MHS, Ph.D.-student
Center for Diabetes Research, Gentofte Hospital, University of Copenhagen, Denmark. Institute of Nursing, University College Metropol, Denmark.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MHS, Ph.D.-student
Study Record Dates
First Submitted
October 21, 2015
First Posted
October 26, 2015
Study Start
August 1, 2015
Primary Completion
December 1, 2018
Study Completion
December 1, 2018
Last Updated
January 3, 2019
Record last verified: 2019-01